ArcticZymes Technologies ASA (AZT.OL)
NOK 16.65
(1.22%)
NOK 16.65
(1.22%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 31.64 Million NOK | -53.51% |
| 2022 | 47.84 Million NOK | -24.21% |
| 2021 | 62.94 Million NOK | 18.67% |
| 2020 | 43.42 Million NOK | 115304.35% |
| 2019 | 3.06 Million NOK | 99.61% |
| 2018 | -10.33 Million NOK | 46.3% |
| 2017 | -22.93 Million NOK | -20.84% |
| 2016 | -18.47 Million NOK | -17.68% |
| 2015 | -15.56 Million NOK | 29.3% |
| 2014 | -22.45 Million NOK | -0.86% |
| 2013 | -22.08 Million NOK | 2.13% |
| 2012 | -22.33 Million NOK | -27.39% |
| 2011 | -18.02 Million NOK | 33.54% |
| 2010 | -25.49 Million NOK | 67.94% |
| 2009 | -82.14 Million NOK | 6.58% |
| 2008 | -74.71 Million NOK | -254.21% |
| 2007 | -35.73 Million NOK | 1573.99% |
| 2006 | 3.4 Million NOK | -93.86% |
| 2005 | 55.45 Million NOK | 1110.03% |
| 2004 | -2.48 Million NOK | 185.32% |
| 2003 | -10.16 Million NOK | -3357.71% |
| 2002 | -155.36 Thousand NOK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 2.25 Million NOK | 177.83% |
| 2024 Q2 | 2.59 Million NOK | -53.72% |
| 2023 Q2 | 6.84 Million NOK | 11.87% |
| 2023 Q1 | 6.11 Million NOK | -17.71% |
| 2023 Q4 | 2.01 Million NOK | -72.24% |
| 2023 FY | - NOK | -53.51% |
| 2023 Q3 | 7.26 Million NOK | 6.11% |
| 2022 Q1 | 27.85 Million NOK | 25.95% |
| 2022 Q2 | 9.53 Million NOK | -65.75% |
| 2022 FY | - NOK | -24.21% |
| 2022 Q3 | 2.83 Million NOK | -70.24% |
| 2022 Q4 | 7.43 Million NOK | 161.89% |
| 2021 Q3 | 8.98 Million NOK | 50.23% |
| 2021 Q2 | 5.98 Million NOK | -76.82% |
| 2021 FY | - NOK | 18.67% |
| 2021 Q1 | 25.8 Million NOK | 1246.17% |
| 2021 Q4 | 22.11 Million NOK | 146.07% |
| 2020 FY | - NOK | 115304.35% |
| 2020 Q4 | 1.91 Million NOK | -81.02% |
| 2020 Q3 | 10.1 Million NOK | -62.89% |
| 2020 Q2 | 27.21 Million NOK | 97.78% |
| 2020 Q1 | 13.76 Million NOK | 287.42% |
| 2019 Q1 | -3.9 Million NOK | -145.08% |
| 2019 FY | - NOK | 99.61% |
| 2019 Q4 | 3.55 Million NOK | 343.45% |
| 2019 Q3 | 801 Thousand NOK | 263.14% |
| 2019 Q2 | -491 Thousand NOK | 87.44% |
| 2018 FY | - NOK | 46.3% |
| 2018 Q1 | -5.86 Million NOK | 8.5% |
| 2018 Q4 | -1.59 Million NOK | -631.65% |
| 2018 Q3 | -218 Thousand NOK | 94.82% |
| 2018 Q2 | -4.2 Million NOK | 28.31% |
| 2017 Q3 | -7.25 Million NOK | -66.59% |
| 2017 Q2 | -4.35 Million NOK | -5.99% |
| 2017 Q1 | -4.1 Million NOK | 44.19% |
| 2017 FY | - NOK | -20.84% |
| 2017 Q4 | -6.41 Million NOK | 11.62% |
| 2016 Q4 | -7.36 Million NOK | -25.24% |
| 2016 Q3 | -5.87 Million NOK | -271.85% |
| 2016 Q1 | -3.45 Million NOK | 58.24% |
| 2016 Q2 | -1.58 Million NOK | 54.24% |
| 2016 FY | - NOK | -17.68% |
| 2015 Q2 | -1.01 Million NOK | 63.53% |
| 2015 FY | - NOK | 29.3% |
| 2015 Q4 | -8.27 Million NOK | -136.24% |
| 2015 Q1 | -2.77 Million NOK | 57.63% |
| 2015 Q3 | -3.5 Million NOK | -246.05% |
| 2014 Q4 | -6.55 Million NOK | -8.59% |
| 2014 FY | - NOK | -0.86% |
| 2014 Q3 | -6.03 Million NOK | -160.45% |
| 2014 Q2 | -2.31 Million NOK | 67.23% |
| 2014 Q1 | -7.06 Million NOK | -6.54% |
| 2013 Q3 | -4.42 Million NOK | 6.53% |
| 2013 Q4 | -6.63 Million NOK | -49.93% |
| 2013 FY | - NOK | 2.13% |
| 2013 Q1 | -6.07 Million NOK | 4.39% |
| 2013 Q2 | -4.73 Million NOK | 22.14% |
| 2012 Q1 | -4.39 Million NOK | 25.74% |
| 2012 Q4 | -6.35 Million NOK | 1.12% |
| 2012 Q3 | -6.43 Million NOK | -19.69% |
| 2012 FY | - NOK | -27.39% |
| 2012 Q2 | -5.37 Million NOK | -22.29% |
| 2011 Q4 | -5.91 Million NOK | -14.27% |
| 2011 Q1 | -2.5 Million NOK | -90.19% |
| 2011 Q2 | -4.82 Million NOK | -93.08% |
| 2011 Q3 | -5.17 Million NOK | -7.21% |
| 2011 FY | - NOK | 33.54% |
| 2010 Q4 | -1.31 Million NOK | 82.83% |
| 2010 Q2 | -5.27 Million NOK | 57.37% |
| 2010 Q1 | -12.37 Million NOK | 0.0% |
| 2010 Q3 | -7.66 Million NOK | -45.16% |
| 2010 FY | - NOK | 67.94% |
| 2009 FY | - NOK | 6.58% |
| 2008 FY | - NOK | -254.21% |
| 2007 FY | - NOK | 1573.99% |
| 2006 FY | - NOK | -93.86% |
| 2005 FY | - NOK | 1110.03% |
| 2004 FY | - NOK | 185.32% |
| 2003 FY | - NOK | -3357.71% |
| 2002 FY | - NOK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Arctic Bioscience AS | -37.78 Million NOK | 183.749% |
| Aqua Bio Technology ASA | -16.56 Million NOK | 291.001% |
| BerGenBio ASA | -191.8 Million NOK | 116.498% |
| Hofseth BioCare ASA | -70.6 Million NOK | 144.82% |
| PCI Biotech Holding ASA | -22.22 Million NOK | 242.399% |
| Thor Medical ASA | -6.82 Million NOK | 563.377% |
| Ultimovacs ASA | -214.85 Million NOK | 114.728% |